Transgenomic Inc. | Mutual Funds
Mutual Funds that own Transgenomic Inc.
Fidelity Growth Company Fund
2,407,451
5.38%
15,724
0.05%
07/31/2018
Fidelity Select Biotechnology Portfolio
1,464,146
3.27%
0
0.17%
07/31/2018
Federated Kaufmann Small Cap Fund
710,195
1.59%
710,195
0.47%
06/29/2018
Fidelity Series Growth Company Fund
633,918
1.42%
4,900
0.05%
07/31/2018
Fidelity Advisor Biotechnology Fund
417,684
0.93%
0
0.15%
07/31/2018
Wells Fargo Advantage Emerging Growth Portfolio
82,190
0.18%
24,114
0.08%
07/31/2018
BlackRock Large Cap Core Plus Fund
31,310
0.07%
31,310
0.06%
06/29/2018
SEI Institutional Managed Trust - Small Cap Growth Fund
28,923
0.07%
0
0.07%
08/31/2018
Wells Fargo Advantage VT - Small Cap Growth Fund
28,868
0.06%
8,256
0.08%
07/31/2018
SEI Institutional Invt. Trust - Small Cap II Fund
20,256
0.05%
0
0.04%
08/31/2018
| Address |
29 Hartwell Avenue
Lexington Massachusetts 02421
United States
|
|
Employees
|
- |
| Website |
http://www.translate.bio |
| Updated |
07/08/2019 |
| Translate Bio, Inc. engages in the research and development of therapeutic drugs. Its proprietary technology to rapidly advance a pipeline of novel drugs for diverse therapeutic areas, with an initial emphasis in the fields of rare genetic disorders, inflammation, oncology, metabolic diseases and neurodegenerative diseases. The company was founded in 2011 and is headquartered in Cambridge, MA. |
